Literature DB >> 3021918

CSF cyclic AMP and CSF adenylate kinase in cerebral ischaemic infarction.

T Büttner, C R Hornig, O Busse, W Dorndorf.   

Abstract

The severity of neurological deficits, size of hypodense zone on CT, concentration of cAMP and activity of adenylate kinase in cerebrospinal fluid (CSF) were evaluated at predefined intervals in the acute stage of supratentorial cerebral ischaemic infarction in 52 patients. Patients with cerebral infarction had raised activities of adenylate kinase CSF as compared with normal persons. Patients with marked neurological deficits, only slight improvement of neurological signs and large infarction zones on CT had higher average activities of adenylate kinase and lower concentration of cAMP in CSF. Alterations of CSF adenylate kinase and CSF cAMP values were most distinct on the 3rd day after the stroke. Reasons for the changes may be metabolic disorders following brain ischaemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021918     DOI: 10.1007/bf00314162

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

1.  [ON THE DETERMINATION OF MYOKINASE (ADENYLATE KINASE) ACTIVITY IN THE SERUM].

Authors:  F H SCHMIDT
Journal:  Klin Wochenschr       Date:  1964-05-15

2.  Adenyl cylase. I. Distribution, preparation, and properties.

Authors:  E W SUTHERLAND; T W RALL; T MENON
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

3.  Cyclic amp concentration and enzyme activities of cerebrospinal fluid in patients with epilepsy or central nervous system damage.

Authors:  V V Myllylä; E R Heikkinen; H Vapaatalo; E Hokkanen
Journal:  Eur Neurol       Date:  1975       Impact factor: 1.710

4.  Radioimmunoassay for the measurement of cyclic nucleotides.

Authors:  A L Steiner; R E Wehmann; C W Parker; D M Kipnis
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

5.  Prognosis among survivors of ischemic stroke.

Authors:  R N Baker; W S Schwartz; J C Ramseyer
Journal:  Neurology       Date:  1968-10       Impact factor: 9.910

6.  Adenylate kinase in central-nervous-system malignancy.

Authors:  E P Getaz; A Bhargava; J Fitzpatrick
Journal:  Lancet       Date:  1979-07-21       Impact factor: 79.321

7.  Cyclic nucleotides in cerebrospinal fluid of patients with intracranial and spinal tumors.

Authors:  H Cramer; E Schindler
Journal:  Acta Neurol Scand       Date:  1982-03       Impact factor: 3.209

8.  The effect of ischemia on biogenic amine concentrations in the central nervous system.

Authors:  J A Zivin; J Stashak
Journal:  Stroke       Date:  1983 Jul-Aug       Impact factor: 7.914

9.  Elevation of cAMP levels in cerebrospinal fluid of patients with neonatal meningitis.

Authors:  C Y Lin; M Ishida
Journal:  Pediatrics       Date:  1983-06       Impact factor: 7.124

10.  Ischemic edema in stroke. A parallel study with computed tomography and cerebrospinal fluid markers of disturbed brain cell metabolism.

Authors:  A Terent; G Ronquist; K Bergström; R Hällgren; H Aberg
Journal:  Stroke       Date:  1981 Jan-Feb       Impact factor: 7.914

View more
  4 in total

1.  Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis.

Authors:  Adeline S L Ng; Joel Kramer; Alejandro Centurion; Josep Dalmau; Eric Huang; Jennifer A Cotter; Michael D Geschwind
Journal:  J Neuroimmunol       Date:  2015-08-08       Impact factor: 3.478

2.  Adenosine neuromodulation and traumatic brain injury.

Authors:  T A Lusardi
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

3.  Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis.

Authors:  Erdem Tüzün; Jeffrey E Rossi; Steve F Karner; Alejandro F Centurion; Josep Dalmau
Journal:  J Neuroimmunol       Date:  2007-04-25       Impact factor: 3.478

4.  Transcriptome analysis reveals differentially expressed genes associated with high rates of egg production in chicken hypothalamic-pituitary-ovarian axis.

Authors:  Shailendra Kumar Mishra; Binlong Chen; Qing Zhu; Zhongxian Xu; Chunyou Ning; Huadong Yin; Yan Wang; Xiaoling Zhao; Xiaolan Fan; Mingyao Yang; Deying Yang; Qingyong Ni; Yan Li; Mingwang Zhang; Diyan Li
Journal:  Sci Rep       Date:  2020-04-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.